Cefatrizine compd with propylene glycol

16 oz (480 ml) Clear ps jar with 89-400 white pp SturdeeSeal® pe foam lined cap attached. Rigid clear polystyrene jars offer glass-like clarity with a smooth surface that is slip-resistant.

16 oz (480 ml) Clear ps jar with 89-400 white pp SturdeeSeal® pe foam lined cap attached. Rigid clear polystyrene jars offer glass-like clarity with a smooth surface that is slip-resistant.

16 oz (480 ml) Clear ps jar with 89-400 white pp SturdeeSeal® pe foam lined cap attached. Rigid clear polystyrene jars offer glass-like clarity with a smooth surface that is slip-resistant.

Purity Limit: &ge 95% (HPLC) CAS No.: 312746-72-8 Molecular Formula: C8H6N2O Molecular Weight: 146.15 MDL No.: MFCD06738281 Appearance: Off-white to yellow solid Storage Temperature: Store at 0-8 °C

General description This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate.

Cas No : 60431-34-7 MDL No : MFCD00153596 MolecularFormula : C27H30O5 MolecularFormula : C27H30O5 Molecular Weight : 434.52 Purity Limit : &gt 95% Storage Temp : Store at 0-8 &degC Appearance : White Powder

Application：Functionalized RAFT agent for controlled radical polymerization: especially suited for the polymerization of styrene: acrylate and acrylamide monomers. NHS ester terminus can be used to conjugate to a variety of biomolecules. Chain

Application：Functionalized RAFT agent for controlled radical polymerization: especially suited for the polymerization of styrene: acrylate and acrylamide monomers. NHS ester terminus can be used to conjugate to a variety of biomolecules. Chain

Application：Functionalized RAFT agent for controlled radical polymerization: especially suited for the polymerization of styrene: acrylate and acrylamide monomers. NHS ester terminus can be used to conjugate to a variety of biomolecules. Chain

Hexose analog that can be incorporated into rat gangliosides GM2 and GD3 in positions normally occupied by galactose. 2-Deoxy-D-galactose has been suggested to act as an inhibitor of fucosylation. It has also been used for competitive elution of

Hexose analog that can be incorporated into rat gangliosides GM2 and GD3 in positions normally occupied by galactose. 2-Deoxy-D-galactose has been suggested to act as an inhibitor of fucosylation. It has also been used for competitive elution of

Hexose analog that can be incorporated into rat gangliosides GM 2 and GD 3 in positions normally occupied by galactose. 2-Deoxy-D-galactose has been suggested to act as an inhibitor of fucosylation.